HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adil J Nazarali Selected Research

3,5-bis(benzylidene)-4-piperidone

2/2013Mitochondrial dysfunction contributes to the cytotoxicity of some 3,5-bis(benzylidene)-4-piperidone derivatives in colon HCT-116 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adil J Nazarali Research Topics

Disease

2Demyelinating Diseases (Demyelinating Disease)
01/2018 - 05/2010
2Neoplasms (Cancer)
01/2016 - 01/2015
1Inflammation (Inflammations)
01/2020
1Relapsing-Remitting Multiple Sclerosis
01/2017
1Carcinogenesis
01/2016
1Multiple Sclerosis
04/2015
1Breast Neoplasms (Breast Cancer)
01/2015
1Mitochondrial Diseases (Mitochondrial Disease)
02/2013
1Alzheimer Disease (Alzheimer's Disease)
01/2012
1Cleft Palate (Palate, Cleft)
09/2010
1Ischemia
11/2008
1Protein-Energy Malnutrition (Marasmus)
11/2008
1Brain Injuries (Brain Injury)
11/2008

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2016
2InterferonsIBA
01/2017 - 04/2015
1Sirtuin 2IBA
01/2020
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2018
1Circular RNAIBA
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Monoclonal AntibodiesIBA
01/2015
1Pharmaceutical PreparationsIBA
01/2015
13,5-bis(benzylidene)-4-piperidoneIBA
02/2013
1EnzymesIBA
01/2012
1Monoamine Oxidase (MAO)IBA
01/2012
1DNA (Deoxyribonucleic Acid)IBA
09/2010
1matrix metalloproteinase 25IBA
09/2010
1CuprizoneIBA
05/2010
1Transcription Factors (Transcription Factor)IBA
11/2008
1salicylhydroxamic acid (SHAM)IBA
11/2008
1NF-kappa B (NF-kB)IBA
11/2008
1Hydrocortisone (Cortisol)FDA LinkGeneric
11/2008
1Glucose (Dextrose)FDA LinkGeneric
11/2008

Therapy/Procedure

2Therapeutics
01/2016 - 01/2015